Altered distribution and function of NK-cell subsets lead to impaired tumor surveillance in JAK2V617F myeloproliferative neoplasms

Author(s):Show less -

Costa, Amanda Fernandes de Oliveira ; Marani, Leticia Olops ; Bianco, Thiago Mantello ; Arantes, Adriana Queiroz ; Lopes, Izabela Aparecida ; Pereira-Martins, Diego Antonio ; Palma, Leonardo Carvalho ; Scheucher, Priscila Santos ; Schiavinato, Josiane Lilian dos Santos ; Binelli, Larissa Sarri ; Silva, Cleide Araujo ; Kobayashi, Susumu S. ; Machado-Neto, Joao Agostinho ; Rego, Eduardo Magalhaes ; Welner, Robert Samuel ; de Figueiredo-Pontes, Lorena Lobo

• Document type: Journal article
• Source: FRONTIERS IN IMMUNOLOGY; v. 13, p. 15-pg., 2022-09-23.

Abstract

In cancer, tumor cells and their neoplastic microenvironment can sculpt the immunogenic phenotype of a developing tumor. In this context, natural killer (NK) cells are subtypes of lymphocytes of the innate immune system recognized for their potential to eliminate neoplastic cells, not only through direct cytolytic activity but also by favoring the development of an adaptive antitumor immune response. Even though the protective effect against leukemia due to NK-cell alloreactivity mediated by the absence of the KIR-ligand has already been shown, and some data on the role of NK cells in myeloproliferative neoplasms (MPN) has been explored, their mechanisms of immune escape have not been fully investigated. It is still unclear whether NK cells can affect the biology of BCR-ABL1-negative MPN and which mechanisms are involved in the control of leukemic stem cell expansion. Aiming to investigate the potential contribution of NK cells to the pathogenesis of MPN, we characterized the frequency, receptor expression, maturation profile, and function of NK cells from a conditional Jak2V617F murine transgenic model, which faithfully resembles the main clinical and laboratory characteristics of human polycythemia vera, and MPN patients. Immunophenotypic analysis was performed to characterize NK frequency, their subtypes, and receptor expression in both mutated and wild-type samples. We observed a higher frequency of total NK cells in JAK2V617F mutated MPN and a maturation arrest that resulted in low-numbered mature CD11b(+) NK cells and increased immature secretory CD27(+) cells in both human and murine mutated samples. In agreement, inhibitory receptors were more expressed in MPN. NK cells from Jak2V617F mice presented a lower potential for proliferation and activation than wild-type NK cells. Colonies generated by murine hematopoietic stem cells (HSC) after mutated or wild-type NK co-culture exposure demonstrated that NK cells from Jak2V617F mice were deficient in regulating differentiation and clonogenic capacity. In conclusion, our findings suggest that NK cells have an immature profile with deficient cytotoxicity that may lead to impaired tumor surveillance in MPN. These data provide a new perspective on the behavior of NK cells in the context of myeloid malignancies and can contribute to the development of new therapeutic strategies, targeting onco-inflammatory pathways that can potentially control transformed HSCs. (AU)

• FAPESP's process: 21/06841-3 - Molecular and phenotypical mechanisms driving immune evasion in myeloid malignancies
• Grantee: Lorena Lôbo de Figueiredo Pontes
• Support Opportunities: Research Grants - Young Investigators Grants - Phase 2
• FAPESP's process: 15/21866-1 - Cytokine-mediated regulation of normal and neoplastic hematopoietic stem cells by natural killer cells
• Grantee: Lorena Lôbo de Figueiredo Pontes
• Support Opportunities: Research Grants - Young Investigators Grants